Raymond Cheong
Direttore/Membro del Consiglio presso TALIS BIOMEDICAL CORPORATION
Patrimonio netto: 671 263 $ in data 30/06/2024
Posizioni attive di Raymond Cheong
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TALIS BIOMEDICAL CORPORATION | Direttore/Membro del Consiglio | 10/03/2023 | - |
| MADRIGAL PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 15/06/2023 | - |
| VTV THERAPEUTICS INC. | Direttore/Membro del Consiglio | 27/02/2024 | - |
| Independent Dir/Board Member | 27/02/2024 | - | |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Direttore/Membro del Consiglio | 01/12/2018 | - |
Storia della carriera di Raymond Cheong
Precedenti posizioni note di Raymond Cheong
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TALIS BIOMEDICAL CORPORATION | Direttore/Membro del Consiglio | 01/06/2020 | 10/06/2022 |
Formazione di Raymond Cheong
| University of Maryland | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Director/Board Member | 5 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| TALIS BIOMEDICAL CORPORATION | Health Technology |
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| VTV THERAPEUTICS INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Health Technology |
- Borsa valori
- Insiders
- Raymond Cheong
- Esperienza
